Microbot Medical
MBOT • NASDAQ
Microbot Medical is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Harel Gadot, with a market cap of $160.5M.
CEOHarel Gadot
Next Earnings
Upcoming earnings announcement for Microbot Medical
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.07
Revenue Estimate
$450.0K
Earnings History
Past 12 earnings reports for Microbot Medical
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Q4 2025 | -$0.04Est: -$0.06 | +33.3% | -Est: $180.0K | -100.0% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.07Est: -$0.03 | -133.3% | -Est: $5.0M | -100.0% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.10Est: -$0.08 | -25.0% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.08Est: -$0.15 | +46.7% | - | — | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$0.19 | — | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.20Est: -$0.17 | -17.6% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.17Est: -$0.17 | 0.0% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.17Est: -$0.17 | 0.0% | - | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$0.26Est: -$0.25 | -4.0% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.21Est: -$0.25 | +16.0% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.25Est: -$0.31 | +19.4% | - | — | 10-Q |
| May 17, 2023 | Q1 2023 | -$0.36 | — | - | — | — |